Clinical Trial

Naples PCI Registry

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the Naples PCI registry is to collect prospective data on baseline clinical, laboratory, and angiographic characteristics of patients undergoing PCI for acute or chronic coronary artery disease. All patients receive clinical follow-up at hospital discharge and at 1-year follow-up with the objective to assess clinical outcomes, including death, cardiovascular death, myocardial infarction, stroke, stent thrombosis, target-lesion and target-vessel revascularization, contrast-induced acute kidney injury, and bleeding events.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-02-10; most recent amendment 2024-02-22.
Status change: Not Yet Recruiting → Recruiting 2022-03-15
Trial Details
NCT Number NCT05248165
Lead Sponsor Federico II University
Conditions Coronary Artery Disease, Percutaneous Coronary Intervention, Myocardial Ischemia, Myocardial Infarction, Acute Coronary Syndrome
Enrollment 5,000 participants
Start Date 2022-03-01
Primary Completion 2032-03-30 (estimated)
Study Completion 2032-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-02-23